Methods: This was a prospective case series of seven eyes with fungal keratitis with anterior chamber involvement or a corneal ulcer refractory to conventional topical treatment. In addition to ...

“Improved fungal keratitis diagnostics, medication delivery systems ... In June 2023, Bausch Health acquired XIIDRA®, a non-steroid eye drops for treating dry eye disease, from Novartis, accreting to ...

Aims: To compare the antifungal efficacy of corneal cross-linking (CXL) and voriconazole in experimental Aspergillus keratitis models ... The corneal tissue of the eye was taken for pathological ...

Immediate treatment was begun with voriconazole 0.02% and amikacin eye drops, intravenous voriconazole and moxifloxacin ... because the clinical and microscopy findings suggestive of fungal ...

When managing an irritated cornea, choosing among fortified antibiotics, oral antivirals, anti-inflammatories or combination ...

One lost to follow-up. † Four grew bacteria; two responded to antifungal medication. Sensitivity: (15 + 2)/(16 + 2) = 0.944 (94%). False positive: 4/(29 - 18) = 0. ...

A list of downloadable documents created during development.

To compare safety, efficacy and cost–effectiveness of voriconazole with natamycin, a double-blinded RCT was conducted in two hospitals in India in 2010. The design was superior to antecedent ...

The FDA is urging consumers to stop using the eye drops and monitor for symptoms of fungal eye infection. Certain eye drops are being recalled over potential fungus contamination, the Food and Drug ...